Bintrafusp Alfa Versus Pembrolizumab in Patients with Treatment-Naive, Programmed Death-Ligand 1-High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial.Byoung Chul Cho,Jong Seok Lee,Yi-Long Wu,Irfan Cicin,Manuel Cobo Dols,Myung-Ju Ahn,Kristof Cuppens,Remi Veillon,Ernest Nadal,Josiane Mourao Dias,Claudio Martin,Martin Reck,Edward B. Garon,Enriqueta Felip, Luis Paz-Ares,Francoise Mornex,Everett E. Vokes,Alex A. Adjei,Clifford Robinson,Masashi Sato,Yulia Vugmeyster,Andreas Machl,Francois Audhuy,Surendra Chaudhary,Fabrice BarlesiJournal of thoracic oncology（2023）引用 0|浏览65暂无评分关键词Bintrafusp alfa,Phase 3,NSCLC,PD-L1AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
